Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely thyroid hormone 120 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely thyroid hormone 180 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Flutamide 125 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Finasteride 1 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely thiamazole 5 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thiamazole 10 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tamoxifen citrate 10mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely pituitary follicle stimulating hormone 75 unit and pituitary luteinizing hormone 75 unit/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary follicle stimulating hormone 150 unit and pituitary luteinising hormone 150 unit powder for solution for injection vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely levothyroxine sodium 38 microgram and liothyronine sodium 9 microgram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thyroxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing propylthiouracil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recomb human follicle stim horm alpha 1200iu powder and solvent for injection solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Follitropin recombinant 75iu/luteinizing hormone 75iu/sodium chloride 9% wv powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fulvestrant 50mg/mL injection solution 5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fulvestrant 50mg/mL injection solution 2.5mL prefilled syringe |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dutasteride (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing precisely dutasteride 500 microgram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyroid hormone measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Brain natriuretic peptide measurement |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine metadrenaline output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine normetadrenaline output |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine normetadrenaline level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine androstenedione level |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine androstenedione output (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
24 hour urine homovanillylmandelic acid output |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine metadrenaline level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing lutropin alfa (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Lutropin alfa 75iu injection (pdr for recon)+solvent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Human luteinizing hormone product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Recombinant human luteinizing hormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Renin and aldosterone (procedure) |
Component |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing drospirenone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Ethinylestradiol+drospirenone 30micrograms/3mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by androgen AND/OR anabolic congener |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chlorotrianisene preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Iothiouracil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by pituitary hormone |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
médicament antithyroidien |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by desoxycorticosterone derivative |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by adrenal cortical steroid |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing metyrapone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natural hormone preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
intoxication par la lévothyroxine sodique |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hypophysiostatic factor preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oral contraceptive preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing thyroid hormone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogenic preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing clomifene citrate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Methylthiouracil-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Androgen receptor agonist-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by phenformin |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by hormone AND/OR synthetic substitute |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Non-steroidal estrogen preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Tamoxifen-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing dextrothyroxine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Estrogen-progestin preparation (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning by vasopressin |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Steroidal estrogen preparation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Poisoning caused by thyroid hormone AND/OR thyroid derivative |
Causative agent (attribute) |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing norgestomet (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing altrenogest (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Synthetic antihormone |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing synthetic antiandrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cyproterone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing flutamide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing synthetic antiestrogen |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing toremifene (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Synthetic antigonadotropin (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Gestrinone-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing paroxypropione (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Exogenous hormones (substance) |
Is a |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Non-sex hormone |
Is a |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fetoplacental hormone |
Is a |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pituitary or adrenal hormone |
Is a |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Placental lactogen measurement |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum total T3 level (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma insulin measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Natriuretic factor (substance) |
Is a |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Implantation of subcutaneous contraceptive (procedure) |
Direct substance |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
Insertion of Norplant |
Direct substance |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Implantation of subcutaneous contraceptive in arm |
Direct substance |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
3 |
Urine catecholamine test |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine measurement, blood (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Dopamine measurement |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Urine free catecholamine measurement |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serum dopamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Plasma catecholamine measurement |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreastatin level (procedure) |
Component |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Blood catecholamine measurement (procedure) |
Component |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Hormone replacement therapy (procedure) |
Direct substance |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hormone implant replacement therapy |
Direct substance |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Hormone replacement therapy ongoing treatment (procedure) |
Direct substance |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Calcium regulating hormone (substance) |
Is a |
True |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing cyclofenil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing androgen receptor antagonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Combined oral contraceptive product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phased cocs- ethinylestradiol+levonorgestrel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Sex hormone product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Phased oral contraceptive |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Fertility agent |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Hormone |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|